"Triple-H" therapy for cerebral vasospasm following subarachnoid hemorrhage.
about
Intracranial hemorrhageReview and recommendations on management of refractory raised intracranial pressure in aneurysmal subarachnoid hemorrhageDopamine D2-receptor-mediated increase in vascular and endothelial NOS activity ameliorates cerebral vasospasm after subarachnoid hemorrhage in vitroNicardipine in the treatment of aneurysmal subarachnoid haemorrhage: a meta-analysis of published data.The efficacy and safety of acupuncture for cerebral vasospasm after subarachnoid hemorrhage: study protocol for a randomized controlled trial.The Relationship between Pulmonary Dysfunction and Age in Vasospasm Patients Receiving Triple H Therapy.Changes in the coagulation and fibrinolytic system of patients with subarachnoid hemorrhage.Delayed ischemia after subarachnoid hemorrhage: result of vasospasm alone or a broader vasculopathy?Cerebral vasospasm in traumatic brain injury.Nurses' prediction of volume status after aneurysmal subarachnoid haemorrhage: a prospective cohort studyPeri-operative medical management of cerebral vasospasm.Neurogenic neuroprotection: clinical perspectivesPerfusion CT to evaluate the effect of transluminal angioplasty on cerebral perfusion in the treatment of vasospasm after subarachnoid hemorrhage.Intensive care management of acute stroke: general management.Subarachnoid hemorrhage: the first 24 hours. A surgeon's perspective.Milrinone and homeostasis to treat cerebral vasospasm associated with subarachnoid hemorrhage: the Montreal Neurological Hospital protocol.Demographic Risk Factors for Vascular Lesions as Etiology of Intraventricular Hemorrhage in Prospectively Screened Cases.Beta Blockade and Clinical Outcomes in Aneurysmal Subarachnoid HemorrhageSafety and efficacy of sildenafil citrate in reversal of cerebral vasospasm: A feasibility study.A new perspective on best transfusion practices.Performance of Third-generation FloTrac/Vigileo system during hyperdynamic therapy for delayed cerebral ischemia after subarachnoid hemorrhage.Low neurologic intensive care unit hemoglobin as a predictor for intra-arterial vasospasm therapy and poor discharge modified Rankin Scale in aneurysmal subarachnoid haemorrhage-induced cerebral vasospasm.Unsecured intracranial aneurysms and induced hypertension in cerebral vasospasm: is induced hypertension safe?Association of early post-procedure hemodynamic management with the outcomes of subarachnoid hemorrhage patients.Effect of HHH-Therapy on Regional CBF after Severe Subarachnoid Hemorrhage Studied by Bedside Xenon-Enhanced CT.Cerebral artery myogenic reactivity: The next frontier in developing effective interventions for subarachnoid hemorrhage.Guidelines on the management of anaemia and red cell transfusion in adult critically ill patients.Asymmetric posterior reversible encephalopathy syndrome complicating hemodynamic augmentation for subarachnoid hemorrhage-associated cerebral vasospasm.Aneurysmal Subarachnoid Hemorrhage.Continual transcranial Doppler in the monitoring of hemodynamic change following aneurysmal subarachnoid hemorrhage.Effect of Hydroxyethyl Starch Solution on Incidence of Acute Kidney Injury in Patients Suffering from Cerebral Vasospasm Following Aneurysmal Subarachnoid Hemorrhage.
P2860
Q26825331-7512DEAD-46A5-4FAB-AA79-1F8D1F1430AEQ26849230-8FDD7E3A-D6DC-494C-88EE-1AD6C07FD568Q30490849-0AABBD9F-C404-4508-929F-3E1526E3369AQ30575416-B2103C38-3BA0-4F74-AE1F-E0B19AA6D980Q35155512-744273D8-8E4C-4523-BE50-2E9BC492F7D9Q35865128-CCFEF0B8-6A39-4F2C-B7AD-5A7E410A10F5Q35943797-725AF630-519C-4A5D-A333-6D8A6F97D3B7Q36937589-6E4182EF-6632-4E4E-BFCC-E2D05D7D072BQ36990532-7F73BDC9-22AD-48CB-AEF6-951A061A060EQ37106029-B981154C-8700-4F12-A06A-0C2FD842965BQ37365474-D309FF42-1BA2-4145-8710-BC30FD798014Q37388330-6AEF8876-37D6-4A24-96EE-17297AF9AF2BQ37433566-6878C420-7976-4E92-916B-535404AD0737Q37599918-24E41996-7867-4AB9-AA86-0851B834C58BQ37809488-3B5E0465-CF1D-4DE1-A2DE-0697E89CFAE6Q38004985-783BF482-5C96-4182-A4A8-3CBC9DFB23F0Q38937219-07747D38-C48B-47DE-A4A4-4E752AEF1FA4Q39143613-990E5A7E-E3E0-4302-9DBA-2EB4BF2567A6Q39251556-B2A61CB6-1BC2-4DC7-801E-A62A809418EAQ39850052-8E768312-9629-4D8E-881F-3214EAE799FAQ42530751-AD2BE42D-450F-409A-AF8A-198B740C2C62Q43697658-F3604534-6443-4031-AF1C-BE54A4BD11B3Q43986518-63984D9A-2344-4A9A-A2BB-7A39BDEF8837Q45158620-10A23257-7AAE-42F0-9586-B73C9DDC6363Q47244570-80D72C5A-C7B8-4DCB-AC9F-1CD47641CF36Q47285240-19F4FF9E-5BC2-4F8F-A512-A410948A36DFQ48231014-63ACAD1A-07B6-46E6-89BD-D11C3593DA77Q50510851-7B23B1E3-0FC2-490A-82AD-EC1B397A4B8DQ53083421-A3D9B604-DE0E-44D6-8CFF-B16604ACF424Q53164531-3D018CF2-91B5-4503-B1A8-97920A7C15C9Q54708941-953DB35C-D4F9-41D6-A6A5-54AA8A37E030
P2860
"Triple-H" therapy for cerebral vasospasm following subarachnoid hemorrhage.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
"Triple-H" therapy for cerebral vasospasm following subarachnoid hemorrhage.
@ast
"Triple-H" therapy for cerebral vasospasm following subarachnoid hemorrhage.
@en
type
label
"Triple-H" therapy for cerebral vasospasm following subarachnoid hemorrhage.
@ast
"Triple-H" therapy for cerebral vasospasm following subarachnoid hemorrhage.
@en
prefLabel
"Triple-H" therapy for cerebral vasospasm following subarachnoid hemorrhage.
@ast
"Triple-H" therapy for cerebral vasospasm following subarachnoid hemorrhage.
@en
P2093
P356
P1433
P1476
"Triple-H" therapy for cerebral vasospasm following subarachnoid hemorrhage.
@en
P2093
Jonathan A Friedman
Kendall H Lee
Timothy Lukovits
P2888
P356
10.1385/NCC:4:1:068
P577
2006-01-01T00:00:00Z
P6179
1000990984